NCT00437905

Brief Summary

The purpose of this study to compare balloon angioplasty (PTA) vs. cutting balloon angioplasty (CB-PTA) in terms of patency and postintervention inflammation in peripheral artery disease.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2003

Longer than P75 for phase_4

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2003

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 21, 2007

Completed
Last Updated

February 21, 2007

Status Verified

February 1, 2007

First QC Date

February 20, 2007

Last Update Submit

February 20, 2007

Conditions

Keywords

peripheral vascular diseasepercutaneous transluminal angioplastycutting balloonballoon angioplastyrandomized controlled trialrestenosisinflammation

Outcome Measures

Primary Outcomes (1)

  • course of postintervention inflammation as indicated by serum levels of C-reactive Protein (CRP+ us-CRP)

Secondary Outcomes (1)

  • occurence of restenosis within 6 months after endovascular treatment

Interventions

angioplastyPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe intermittent claucication (Fontaine stage IIb)or limb ischemia, femoropoliteal stenosis/occlusion up to 5 cm length

You may not qualify if:

  • Previous bypass surgery at the site of treatment,
  • Previous stent placement at or immediatly adjacent to target lesion,
  • History of anti-platelet-therapy intolerance or adverse reaction to heparin,
  • Bleeding diathesis,
  • Creatinine \> 2,5 mg/dL,
  • Active bacterial infection,
  • Allergy to contrast media

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Amighi J, Schillinger M, Dick P, Schlager O, Sabeti S, Mlekusch W, Haumer M, Mathies R, Heinzle G, Schuster A, Loewe C, Koppensteiner R, Lammer J, Minar E, Cejna M. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial. Radiology. 2008 Apr;247(1):267-72. doi: 10.1148/radiol.2471070749. Epub 2008 Feb 12.

MeSH Terms

Conditions

Peripheral Vascular DiseasesIntermittent ClaudicationAtherosclerosisInflammation

Interventions

Angioplasty

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPeripheral Arterial DiseaseSigns and SymptomsPathological Conditions, Signs and SymptomsArteriosclerosisArterial Occlusive DiseasesPathologic Processes

Intervention Hierarchy (Ancestors)

CatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Jasmin Amighi, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR
  • Martin Schillinger, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR
  • Manfred Cejna, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 20, 2007

First Posted

February 21, 2007

Study Start

June 1, 2003

Study Completion

January 1, 2007

Last Updated

February 21, 2007

Record last verified: 2007-02